Milbemycin oxime

Star0

DB11531ExperimentalVet approvedSmall molecule

Milbemycin oxime: Overview.

Formula / weight: C₆₃H₈₈N₂O₁₄ · 1097.397 g/mol (avg)
Code names: CGA-179246

Resolves to

Compound

UNII0502PUN0GTCAS129496-10-2

Clinical / RWD

RxNorm68730

Structure

InChIKeyCKVMAPHTVCTEMM-ALPQRHTBSA-NSMILES

[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C)O5)O4)OC(=O)[C@]([H])(C=C(C)\C1=N\O)[C@@]23O.[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@H](C[C@]5(CC[C@H](C)[C@@H](CC)O5)O4)OC(=O)[C@]([H])(C=C(C)\C1=N\O)[C@@]23O

What you can answer from here — as of March 06, 2025

10Marketed productsAcross 1 country and 2 labellers

Which companies are running trials of Milbemycin oxime, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account